Hemorrhagic Fever, Ebola - 4 Studies Found

Not yet recruiting : African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
: Ebola
: 2016-12-22
:
  • Biological: V920 (rVSVΔG-ZEBOV-GP) Ebola Virus Vaccine

Recruiting : Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen
: Ebola Virus Survivor
: 2016-02-24
: Drug: Favipiravir Cohort 1: Day 1 (inclusion) 4800 mg (240
Completed : GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen
: Persistent Ebola Virus
: 2016-06-28
:
  • Drug: GS-5734 Daily GS-5734 de
Active, not recruiting : Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012)
: Prevention of Ebola Infection
: 2015-07-17
:
  • Biological: V920 Consistency Lot A